Cymabay Therapeutics Inc (NASDAQ:CBAY)

3.77
Delayed Data
As of Nov 26
 -0.03 / -0.79%
Today’s Change
3.39
Today|||52-Week Range
7.77
-34.32%
Year-to-Date

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Cymabay Therapeutics Inc have a median target of 11.50, with a high estimate of 14.00 and a low estimate of 7.00. The median estimate represents a +205.04% increase from the last price of 3.77.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Cymabay Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.27
Sales
$5.6M
Reporting Date
Mar 24

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 17.17%
 
 
 
 
 
 
Growthannually -56.16%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.